尼普利辛抑制通过CNP/NPR-B通路促进骨生长
Takuro Hakata1, Yohei Ueda1, Takafumi Yamashita2
1Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
Endocrinology
|May 16, 2024
概括
用sacubitril抑制 neprilysin (NEP) 通过增加C型性尿素 (CNP) 水平来促进骨生长. 这种方法对治疗受损生长条件有希望.
科学领域:
- 骨生物学 骨生物学
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- C型尿性 (CNP) 对于内分泌骨生长至关重要.
- CNP的短半衰期限制了其在骨生长障碍方面的治疗潜力.
- 尼普利辛 (NEP) 降解了CNP,使其成为延长CNP作用的目标.
研究的目的:
- 为了研究NEP抑制对骨生长的影响.
- 为了确定NEP抑制是否可以通过CNP途径增强骨生长.
主要方法:
- 给C57BL/6小鼠服用萨库比特里尔 (一种NEP抑制剂).
- 对生长板进行了组织学分析.
- 使用了缺乏软骨特异性尿素受体B (NPR-B) 的淘汰赛小鼠.
- 进行了器官培养实验,使用胎儿小鼠的骨扩张.
主要成果:
- 在小鼠中,萨库比特里尔的使用导致了剂量依赖的骨过度生长.
- 组织学显示,生长板中的增生和增区变厚.
- 在NPR-B淘汰赛小鼠中,萨库比特里的增长促进作用被废除了.
- 在3至4周大的小鼠中观察到骨生长促进,其内源性CNP和NEP水平较高.
结论:
- 抑制NEP可通过CNP/NPR-B信号通路显著促进骨生长.
- 向NEP提供了一个潜在的治疗策略,用于特征是骨生长受损的条件.
- 需要进一步的研究,以在矮个体中进行临床应用.
相关概念视频
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K


